Antigen presentation to T cells in nonlymphoid tissue
Antigen presentation to T cells in nonlymphoid tissue
批准号:
7213343
负责人:
James B McLachlan
金额:
$3.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2007-09-30
中文摘要
描述(由申请方提供):已经明确,次级淋巴器官中的抗原呈递对于抗原特异性适应性免疫应答的启动至关重要。这种应答的初级阶段由树突状细胞在MHC II背景下的抗原呈递组成,然后由CD4+ T细胞识别,CD4+ T细胞继而可以被激活。活化的效应CD4+ T细胞迁移回抗原沉积部位,在那里它们可以保留数周。该建议旨在确定抗原呈递在非淋巴组织中对CD4+ T细胞的作用。虽然我们预期组织中的炎性环境同等地启动效应T细胞的进入,但我们假设为了发生最大积累、隔离和持续活化,抗原特异性T细胞必须在抗原沉积的实际位点处的MHC II背景下识别同源抗原。我们的假设是,虽然树突状细胞活化淋巴结中的T细胞,但组织中的巨噬细胞负责抗原沉积部位的抗原呈递以及CD4+ T细胞的持续活化和保留。
英文摘要
DESCRIPTION (provided by applicant): It has been well established that antigen presentation in secondary lymphoid organs is essential for the initiation of an antigen specific adaptive immune response. The primary phase of this response consists of antigen presentation by dendritic cells in the context of MHC II where it is then recognized by CD4+ T cells which in turn can become activated. Activated effector CD4+ T cells migrate back into sites of antigen deposition where they can remain for weeks. This proposal seeks to determine the role of antigen presentation in nonlymphoid tissues with respect to its effect on CD4+ T cells. While we expect that the inflammatory milieu in the tissue initiates the entry of effector T cells equally, we hypothesize that in order for maximal accumulation, sequestration, and sustained activation to occur, antigen-specific T cells must recognize cognate antigen in the context of MHC II at the actual site of antigen deposition. Our hypothesis is that while dendritic cells activate T cells in the lymph nodes, macrophages in the tissue is responsible for antigen presentation at the site of antigen deposition and for the sustained activation and retention of CD4+ T cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using combination adjuvants to direct and control immune responses at the intestinal mucosa
-
批准号:9108588
-
项目类别:
-
资助金额:$39.33万
-
财政年份:2016
-
负责人:James B McLachlan
-
依托单位:
Mast cell control of endogenous, antigen-specific CD4 T cell immunity
-
批准号:9019796
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2016
-
负责人:James B McLachlan
-
依托单位:
Using combination adjuvants to direct and control immune responses at the intestinal mucosa
-
批准号:9247816
-
项目类别:
-
资助金额:$54.66万
-
财政年份:2016
-
负责人:James B McLachlan
-
依托单位:
Using combination adjuvants to direct and control immune responses at the intestinal mucosa
-
批准号:9897616
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2016
-
负责人:James B McLachlan
-
依托单位:
Organ-specific CD4 T cell responses regulate Salmonella persistence
-
批准号:8868025
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2013
-
负责人:James B McLachlan
-
依托单位:
Organ-specific CD4 T cell responses regulate Salmonella persistence
-
批准号:8703005
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2013
-
负责人:James B McLachlan
-
依托单位:
Organ-specific CD4 T cell responses regulate Salmonella persistence
-
批准号:9085228
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2013
-
负责人:James B McLachlan
-
依托单位:
Organ-specific CD4 T cell responses regulate Salmonella persistence
-
批准号:8578801
-
项目类别:
-
资助金额:$35.37万
-
财政年份:2013
-
负责人:James B McLachlan
-
依托单位:
Antigen presentation to T cells in nonlymphoid tissue
-
批准号:7054953
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2006
-
负责人:James B McLachlan
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: